Announcement on Completion of Inclusion of the First Subject in Phase 1 Clinical Trial of CIGB-814 for Injection

About this update from Shandong Lukang Pharmaceutical Co., Ltd. Class A

Announcement on Completion of Inclusion of the First Subject in Phase 1 Clinical Trial of CIGB-814 for InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shandong Lukang Pharmaceutical Co., Ltd. Class A